Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2006-06-13
2006-06-13
Wax, Robert A. (Department: 1653)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S468000, C424S485000, C424S486000, C424S488000, C530S421000
Reexamination Certificate
active
07060299
ABSTRACT:
Disclosed herein are biodegradable microparticle compositions, and methods for the generation of biodegradable and biocompatible microparticles that stabilize proteins and also control the kinetics of release of proteins over a period of several weeks to several months under physiological conditions.
REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 3887699 (1975-06-01), Yolles
patent: 4293339 (1981-10-01), Supcoe et al.
patent: 4675189 (1987-06-01), Kent et al.
patent: 5700486 (1997-12-01), Canal et al.
patent: 5759583 (1998-06-01), Iwamoto et al.
patent: 5981719 (1999-11-01), Woiszwillo et al.
patent: 5985309 (1999-11-01), Edwards et al.
patent: 6120787 (2000-09-01), Gustafsson et al.
patent: 6238705 (2001-05-01), Liu et al.
patent: 6294202 (2001-09-01), Burns et al.
patent: 6391296 (2002-05-01), Okano et al.
patent: 6896894 (2005-05-01), Brody et al.
patent: 0 950 663 (1999-10-01), None
patent: WO 02/28370 (2002-04-01), None
Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Gaozhong Zhu, Susan R. Mallery, and Steven P. Schwendeman. Nature Biotechnology. 2001: 18:52-57.
Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. Morlock M, Kissel T, Li YX, Koll H, Winter G. J. Controlled Release. 1998: 56: 105-115.
Concentration and fractionation of polyvinyl alcohol-anionic surfactant stabilised latex dispersions by microfiltration. R.J. Wakeman *, G. Akay. 1995. J. Membrane Science. 106:57-65.
Austin et al.; The Controlled Release of Leukaemia Inhibitory Factor (LIF) From Aliginate Gels; Pro Intern Symp Control Rel Bioact Mater; 23; 1996; pp. 739-740.
Brannon-Peppeas et al.; Polyactic and Polyglycolic Acids as Drug Delivery Carriers; Handbook of Pharmaceutical Release Tech; 2000; pp. 99-130; Marcel Dekker; New York.
Burgess et al.; Glucuronidase Activity Following Complex Coacervation & Spray Drying Micoencapsulation; J. Microencapsulation; 1998; vol. 15; No. 5; pp. 569-579.
Burke, Paul; Controlled Relase Protein Therapeutics: Effects of Process & Formulation on Stability; Handbook of Pharmaceutical Controlled Release Tech; 2000; pp. 661-692.
Chang, Thomas; Biodegradable Semipermeable Microcapsules Containing Enzymes Hormones Vaccines & Other Biologicals; J of Bioengineering; 1976; vol. 1; pp. 25-32.
Chen et al. Polysaccharide Hydrogels for Protein Drug Delivery; Carbohydrate Polymers 28; 1995; pp. 69-76; Elsevier; Great Britain.
Cleland et al.; Stable Formulations of Recombinant Human Growth Hormone & Interferon-for Microencapsulation in Biodegradable Microspheres; Pharmaceutical Research; vol. 13; No. 10; 1996; pp. 1464-1475.
Crotts et al. Protein Delivery From Poly(lactic-co-glycolic acid) Biodegradable Microspheres: Release Kinetics & Stability Issues; J Microencapsulation 1998; 15; 6; pp. 699-713.
De Rosa et al; Influence of Co-encapsulation of Different Non-Ionic Surfactants on the Properties of PLGA Insulin-loaded Microspheres; J Controlled Release 69 2000 pp. 283-295.
Gombotz et al.; Protein Release From Alginate Matrices; Advanced Drug Delivery Reviews; 31; 1998; pp. 267-285; Elsevier.
Huang et al.; On The Importance & Mechanismsof Burst Release in Matrix-controlled Drug elivery Systems; J of Controlled Release; 73; 2001; pp. 121-136; Elsevier.
Jain et al.; Controlled Drug Delivery by Biodegradable Poly(Ester) Devices: Different Preparative Approaches; Drug Development & Industrial Pharmacy; 1998; vol. 24; pp. 703-727.
Jiang et al.; Stabilization & Controlled Release of Bovine Serum Albumin Encapsulated in Poly(D, L-lactide) and Poly(ethylene glycol) Microsphere Blends; Pharmaceutical Research; vol. 18; 6; 2001; pp. 878-885.
Johansen et al; Improving Stability & Release Kinetics of Microencapsulated Tetanus Toxoid by Co-Encapsulation of Additives; Pharmaceutical Reseach vol. 15; 7 1998 pp. 1103-1110.
Lee et al.; Double Walled Microparticles For HBV Single Shot Vaccine; Proceed Intern Symp Control Rel Bioact Mater; 23; 1996; pp. 333-334; #4103; Controlled Release Soc.
Li et al.; A Novel Biodegradable System Based on Gelatin Nanoparticles and Poly(lactic-co-gylcolic acid) Microspheres for Protein and Peptide Drug Delivery; J Pharmaceutical Sciences; vol. 86; No. 8; Aug. 1997; pp. 891-895.
Park et al.; Poly(L-lactic acid) Pluronic Blends: Characterization of Phase Separation Behavior, Degradation and Morphology and Use as Protein-Releasing Matrices; Macromolecules; 1992; 25; pp. 116-122; American Chemical Society.
Patil et al.; Water-Based Microsphere Delivery System for Proteins; J of Pharmaceutical Sciences; vol. 89; No. 1; Jan. 2000; pp. 9-15.
Pean et al.; Why Does PEG 400 Co-Encapsulation Improve NGF Stability & Release From PLGA Biodegradable Microspheres; Pharmaceutical Research; vol. 16; No. 8; 1999; pp. 1294-1299.
Prokop et al.; Water Soluble Polymers for Immunoisolation II: Evaluation of Multicomponent Microencapsulation Systems; Advances in Polymer Science; vol. 136; pp. 53-73; 1998.
Putney et al.; Encapsulation of Proteins for Improved Delivery; Current Opinion In Chemical Biology; 1998; 2 pp. 548-552.
Roskos et al.; Degradable Controlled Release Systems Useful for Protein Delivery; Protein Delivery: Physical Systems, Sanders & Hendren eds.; Plenum Press; NY; pp. 45-92; 1997.
Sanchez et al.; Formulation Strategies for Stabilization of Tetanus Toxoid in Poly (lactide-co-glycolide) Microspheres; Inter J of Pharmaceutics; 185; 1999 pp. 255-266; Elsevier.
Sandor et al.; Effect of Protein Molecular Weight on Release From Micro-Sized PLGA Micoospheres; J of Controlled Release; 76; 2001; pp. 297-311; Elsevier.
Sezer et al.; Release Characteristics of Chitosan Treated Alginate Beads: I. Susteained Release of a Macromolecular Drug From Chitosan Treated Alginate Beads; J Microencapsulation; 1999; vol. 16; No. 2; pp. 195-203.
Van De Weert et al.; Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles; Pharnaceutical Research; vol. 17; No. 10; 2000; pp. 1159-1167.
Wang et al.; A heterogenously Structured Composite Based on Poly(lactic-co-glycolic acid) Microspheres and Poly (vinyl alcohol) Hydrogel Nanoparticles for Long-Term Protein Drug Delivery; Pharmaceutical Research; vol. 16; No. 9; 1999; pp. 1430-1435.
Wang et al.; A Novel Approach to Stabilization of Protein Drugs in Poly(lactic-co-glycolic acid)microspheres Using Agarose Hydrogel; Inernational Journal of Pharmaceutics; 166; 1998; pp. 1-14.
Wheatley et al.; Coated Alginate Microspheres: Factors Influencing the Controlled Deliery of Macromolecules; J of Applied Polymer Science; vol. 43; pp. 2123-2135; 1991.
Woo et al.; Preparation adn Characterization of a Composite PLGA and Poly(Acrylol Hydroxyethyl Starch) Microsphere System for Protein Delivery; Pharmaceutical Research; vol. 18; No. 11; Nov. 1002; pp. 1600-1606.
Alavattam Sreedhara
Brody Richard S.
Battelle (Memorial Institute)
Wax Robert A.
Wiesmann Klaus H.
LandOfFree
Biodegradable microparticles that stabilize and control the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biodegradable microparticles that stabilize and control the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biodegradable microparticles that stabilize and control the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3637159